Central α1-adrenoceptors: Their role in the modulation of attention and memory formation

Pharmacology and Therapeutics

Volumn 83, Issue 1, 1999, Pages 49-65

  Sirviö, Jouni ^a,b   MacDonald, Ewen ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Adrenoceptors; Arousal; Cognitive functions; Learning and memory; Long term potentiation; Noradrenaline

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; NORADRENALIN; ALPHA 1 ADRENERGIC RECEPTOR;

AROUSAL; COGNITION; HUMAN; LEARNING; LOCOMOTION; LONG TERM POTENTIATION; MEMORY; MODULATION; NERVE CELL PLASTICITY; PRIORITY JOURNAL; REVIEW; SYNAPTIC TRANSMISSION; ANIMAL; ATTENTION; BRAIN; HIPPOCAMPUS; PHYSIOLOGY;

ANIMALS; AROUSAL; ATTENTION; BRAIN; COGNITION; HIPPOCAMPUS; HUMANS; LEARNING; LONG-TERM POTENTIATION; MEMORY; RECEPTORS, ADRENERGIC, ALPHA-1; SYNAPTIC TRANSMISSION;

EID: 0032589306     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(99)00017-0     Document Type: Review

References (161)

1. Andersson J.L., Marcus M., Nomikos G.G., Svensson T.H. Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not in the nigrostriatal dopamine system. Naunyn Schmiedebergs Arch Pharmacol. 349:1994;236-243.
2. Arai A., Silberg J., Lynch G. Differences in the refractory properties of two distinct inhibitory circuitries in field CA1 of the hippocampus. Brain Res. 704:1995;298-306.
3. Araneda R., Andrade R. 5-Hydroxytryptamine 2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience. 40:1991;399-412.
4. Arnsten A.F.T., Jentsch J.D. The alpha-1 adrenergic agonist, cirazoline, impairs spatial working memory performance in aged monkeys. Pharmacol Biochem Behav. 58:1997;55-59.
5. Arnsten A.F.T., Steere J.C., Hunt R.D. The contribution of α2-noradrenergic mechanisms to prefrontal cortical cognitive function - potential significance for attention deficit hyperactivity disorder. Arch Gen Psychiatry. 53:1996;448-455.
6. Arnsten A.F.T., Steere J.C., Jentsch D.J., Li B.M. Noradrenergic influences on prefrontal cortical cognitive function. opposing actions at postjunctional alpha 1 versus alpha 2-adrenergic receptors Adv Pharmacol. 42:1998;764-767.
7. Artola A., Singer W. Long-term depression of excitatory synaptic transmission and its relationship to long-term potentiation. Trends Neurosci. 16:1993;480-487.
8. Aston-Jones G., Chiang C., Alexinsky T. Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance. Barnes C.D., Pompeiano O. Progress in Brain Research (. 1991;501-520 Elsevier, Amsterdam.
9. Bergles D.E., Doze V.A., Madison D.V., Smith S.J. Excitatory actions of norepinephrine on multiple classes of hippocampal CA1 interneurons. J Neurosci. 16:1996;572-585.
10. Bergstrom D.A., Kellar K.J. Effect of convulsive shock on monoaminergic receptor binding sites in rat brain. Nature. 278:1980;464-466.
11. Berridge C.W., Foote S.L. Locus-coeruleus-induced modulation of forebrain electroencephalographic (EEG) state in halothane-anesthetized rat. Brain Res Bull. 35:1994;597-605.
12. Berridge C.W., Foote S.L. Enhancement of behavioral and electroencephalographic indices of waking following stimulation of noradrenergic β-receptors within the medial septal region of the basal forebrain. J Neurosci. 16:1996;6999-7009.
13. 1-adrenoceptor effect in hippocampal slices. Eur J Pharmacol. 166:1989;183-191.
14. 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical d-amphetamine injection. Eur J Neurosci. 6:1994;293-298.
15. Bliss T.V.P., Collingridge G.L. A synaptic model of memory. long-term potentiation in the hippocampus Nature. 361:1993;31-39.
16. Brocher S., Artola A., Singer W. Agonists of cholinergic and noradrenergic receptors facilitate synergistically the induction of long-term potentiation in slices of rat visual cortex. Brain Res. 573:1992;27-36.
17. Buzsaki G. Two stage model of memory trace formation. a role for "noisy" brain states Neuroscience. 31:1989;551-570.
18. Buzsaki G., Kennedy B., Solt V.B., Ziegler M. Noradrenergic control of thalamic oscillation. the role of α-2 receptors Eur J Neurosci. 3:1990;222-229.
19. Bylund D.B., Eikenberg D.C., Hieble J.P., Langer S.Z., Lefkowitz R.J., Minneman K.P., Molinoff P.B., Ruffolo R.R. Jr., Trendelenburg U. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev. 46:1994;121-136.
20. Cavalli A., Lattion A.L., Hummler E., Nenniger M., Pedrazzini T., Aubert J.F., Michel M.C., Yang M., Lembo G., Vecchione C., Mostardini M., Schmidt A., Beerman F., Cotecchia S. Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor. Proc Natl Acad Sci USA. 94:1997;11589-11594.
21. Chessell I.P., Francis P.T., Pangalos M.N., Pearson R.C.A., Bowen D.M. Localisation of muscarinic (m1) and other neurotransmitter receptors on corticofugal-projecting pyramidal neurones. Brain Res. 632:1993;86-94.
22. Christ G.J., Brink P.R., Zhao W., Moss J., Gondre C.M., Roy C., Spray D.C. Gap junctions modulate tissue contractility and alpha 1 adrenergic agonist efficacy in isolated rat aorta. J Pharmacol Exp Ther. 266:1993;1054-1065.
23. Coan E.J., Irving A.J., Collingridge G.L. Low-frequency activation of the NMDA receptor system can prevent the induction of LTP. Neurosci Lett. 105:1989;205-210.
24. Cole B.J., Robbins T.W. Forebrain norepinephrine. role in controlled information processing in the rat Neuropsychopharmacology. 7:1992;129-142.
25. 1-adrenergic receptor. Proc Natl Acad Sci USA. 85:1988;7159-7163.
26. Cotecchia S., Kobilka B.K., Daniel K.W., Nolan R.D., Lapetina E.G., Caron M.G., Lefkowitz R.J., Regan J.W. Multiple second messenger pathways of α-adrenergic receptor subtypes expressed in eukaryotic cells. J Biol Chem. 265:1990;63-69.
27. Coull J.T. Pharmacological manipulations of the alpha 2-noradrenergic system. Effects of cognition. Drugs Aging. 5:1994;116-126.
28. Curet O., Montigny C. Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. II. Receptors mediating the effect of synaptically released norepinephrine. Brain Res. 475:1988;47-57.
29. Darracq L., Blanc G., Glowinski J., Tassin J.-P. Importance of the noradrenergic-dopamine coupling in the locomotor activating effects of d-amphetamine. J Neurosci. 18:1998;2729-2739.
30. 1d-adrenergic receptor mRNA in the rat brain and spinal cord. J Chem Neuroanat. 13:1997;115-139.
31. Decker M.W., Gill T.M., McGaugh J.L. Concurrent muscarinic and β-adrenergic blockade in rats impairs place-learning in a water maze and retention of inhibitory avoidance. Brain Res. 513:1990;81-85.
32. 1-adrenoceptor agonist. 2-(2-chloro-5-trifluoromethylphenyl-imino)imidazolidine (St 587) Life Sci. 28:1981;2009-2016.
33. De Sereville J.E., Boer C., Rambert F.A., Duteil J. Lack of presynaptic dopaminergic involvement in modafinil activity in anaesthetized mice. in vivo voltammetry studies Neuropharmacology. 33:1994;755-761.
34. Devagues V., Sara S.J. Memory retrieval enhancement by locus coeruleus stimulation. evidence for mediation by β-receptors Behav Brain Res. 43:1991;93-97.
35. Dingledine, R. (Ed.). (1984). Brain Slices. New York: Plenum Press.
36. Doze V.A., Cohen G.A., Madison D.V. Synaptic localization of adrenergic disinhibition in the rat hippocampus. Neuron. 6:1991;889-900.
37. Duffy S., MacVicar B.A. Adrenergic calcium signalling in astrocyte networks within the hippocampal slice. J Neurosci. 15:1995;5535-5550.
38. Dunwiddie T.V., Taylor M., Heginbotham L.R., Proctor W.R. Long-term increases in excitability in the CA1 region of rat hippocampus induced by β-adrenergic stimulation. possible mediation by cAMP J Neurosci. 12:1992;506-517.
39. Duteil J., de Sereville J.-E., Boer C., Rambert F.A. Lack of dopaminergic involvement in modafinil, but not amphetamine and methylphenidate, activity in anaesthetized mice and rats. in vivo voltammetry studies Eur J Pharmacol. 183:1990;1406-1407. a.
40. 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur J Pharmacol. 180:1990;49-58. b.
41. 1-Adrenoceptor agonists behave like dopamine D1 agonists in reinstating quinpirole-induced locomotor stimulation blocked by dopamine depletion in mice. Eur J Pharmacol. 183:1990;407.
42. Everitt B.J., Robbins T.W. Central cholinergic systems and cognition. Annu Rev Psychol. 48:1997;649-684.
43. Eysenck M.W. Principles of Cognitive Psychology. 1993;Lawrence Erlbaum Associates Ltd, Hove, England.
44. Fallon J.H., Loughlin S.E. Monoamine innervation of cerebral cortex and a theory of the role of monoamines in cerebral cortex and basal ganglia. Jones E.G., Peters A. Cerebral Cortex (. 1987;41-127 Plenum Press, New York.
45. Feeney D.M., Weisend M., Kline A.E. Noradrenergic pharmacotherapy, intracerebral infusion and adrenal transplantation promote functional recovery after cortical damage. J Neural Transplant Plast. 4:1993;199-213.
46. Ferraro L., Tanganelli S., O'Connor W.T., Antonelli T., Rambert F., Fuxe K. The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur J Pharmacol. 306:1996;33-39.
47. Ferry B., Magistretti P.J., Pralong E. Noradrenaline modulates glutamate-mediated neurotransmission in the rat basolateral amygdala in vitro. Eur J Neurosci. 9:1997;1356-1364.
48. Fibiger H.C. Mesolimbic dopamine. an analysis of its role in motivated behaviour Semin Neurosci. 5:1993;321-327.
49. Fillenz M. Noradrenergic Neurons. 1990;Cambridge University Press, Cambridge.
50. Floresco S.B., Seamans J.K., Phillips A.G. Selective roles for hippocampal, prefrontal cortical, and ventral striatal circuits in radial-arm maze tasks with or without a delay. J Neurosci. 17:1997;1880-1890.
51. Foote S.L., Morrison J.H. Extrathalamic modulation of cortical function. Annu Rev Neurosci. 10:1987;67-95.
52. 1-adrenoceptor classification Br J Pharmacol. 121:1997;1127-1135.
53. Fritschy J.-M., Grzanna R. Restoration of ascending noradrenergic projections by residual locus coeruleus neurons. compensatory response to neurotoxin-induced cell death in the adult rat brain J Comp Neurol. 321:1992;421-441.
54. Fry J.M. Treatment modalities for narcolepsy. Neurology. 50(suppl. 1):1998;S43-S48.
55. Goldman-Rakic P.S. Space and time in the mental universe. Nature. 386:1997;559-560.
56. Goldman-Rakic P.S., Lidow M.S., Gallagher D.W. Overlap of dopaminergic, adrenergic and serotonergic receptors and complementarity of their subtypes in primate prefrontal cortex. J Neurosci. 10:1990;2125-2138.
57. Green S. Principles of Biopsychology. 1994;Lawrence Erlbaum Associates Ltd, Hove, England.
58. Grenhoff J., Svensson T.H. Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur J Pharmacol. 233:1993;79-84.
59. Harley C.W. A role for norepinephrine in arousal, emotion and learning? limbic modulation by norepinephrine and the Kety hypothesis Prog Neuropsychopharmacol Biol Psychiatry. 11:1987;419-456.
60. Harley C. Noradrenergic and locus coeruleus modulation of the perforant path-evoked potential in rat dentate gyrus supports a role for the locus coeruleus in attentional and memorial processes. Prog Brain Res. 88:1991;307-321.
61. Heal D.J. The effects of drugs on behavioural models of central noradrenergic function. Heal D.J., Marsden D.A. The Pharmacology of Noradrenaline in the Central Nervous System (. 1990;266-315 Oxford University Press, New York.
62. Hermant J.F., Rambert F.A., Duteil J. Awakening properties of modafinil. effect on nocturnal activity in monkeys (Macaca mulatta) after acute and repeated administration Psychopharmacology. 103:1991;28-32.
63. 1-adrenoceptors. consensus update Pharmacol Rev. 47:1995;267-270.
64. Hjorth S., Bengtsson H.J., Milano S., Lundberg J.F., Sharp T. Studies on the role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release-I. BMY7378 and prazosin. Neuropharmacology. 34:1995;615-620.
65. Holets V.R. The anatomy and function of noradrenaline in the mammalian brain. Heal D.J., Marsden C.A. The Pharmacology of Noradrenaline in the Central Nervous System (. 1990;1-40 Oxford University Press, New York.
66. Hopkins W.F., Johnston D. Noradrenergic enhancement of long term potentiation at mossy fiber synapses in the hippocampus. J Neurophysiol. 59:1988;667-687.
67. Huang Y.-Y., Kandel E.R. Modulation of both an early and the late phase of mossy fiber LTP by the activation of β-adrenergic receptors. Neuron. 16:1996;611-617.
68. Introini-Collison I., Saghafi D., Novack G.D., McGaugh J.L. Memory-enhancing effects of post-training dipivefrin and epinephrine. involvement of peripheral and central adrenergic receptors Brain Res. 572:1992;81-86.
69. Izquierdo I., Medina J.H. Memory formation. the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures Neurobiol Learn Mem. 68:1997;285-316.
70. Izumi Y., Clifford D.B., Zorumski C.F. Norepinephrine reverses N-methyl-D-aspartate-mediated inhibition of long-term potentiation in rat hippocampal slices. Neurosci Lett. 142:1992;163-166.
71. Jacobs B.L. Locus coeruleus neuronal activity in behaving animals. Heal D.J., Marsden C.A. The Pharmacology of Noradrenaline in the Central Nervous System (. 1990;248-264 Oxford University Press, New York.
72. Jansson C.C., Marjamäki A., Luomala K., Savola J.-M., Scheinin M., Åkerman K. Coupling of human α2-adrenoceptor subtypes to regulation of cAMP production in transfected S115 cells. Eur J Pharmacol. 266:1994;165-174.
73. Johnston, D., & Amaral, D. G. (1998). Hippocampus. In G. M. Shepherd (Ed.), The Synaptic Organization of the Brain, 4th edn. (pp. 417-458). New York: Oxford University Press.
74. 1 noradrenergic receptors. Neuroscience. 66:1995;539-545.
75. Kalkman H.O., Neumann V. Evidence for a 5-HT1D receptor-mediated hypothermic effect of the alpha 1-adrenoceptor agonist, SDZ NVI-085, in guinea-pigs. Eur J Pharmacol. 285:1995;313-315.
76. 1L-Adrenoceptor mediation of smooth muscle contraction in rabbit bladder neck. a model for lower urinary tract tissue of man Br J Pharmacol. 123:1998;1359-1366.
77. Lachnit W.G., Ford A.P., Clarke D.E. SDZ NVI 085, an alpha 1A-adrenoceptor agonist with 5-HT2A receptor antagonist properties. Eur J Pharmacol. 297:1996;83-86.
78. Lacroix D., Ferron A. Electrophysiological effects of methylphenidate on the coeruleo-cortical noradrenergic system in the rat. Eur J Pharmacol. 149:1988;277-285.
79. Law-Tho D., Crepel F., Hirsch J.C. Noradrenaline decreases transmission of NMDA- and non-NMDA-receptor mediated monosynaptic EPSPs in rat prefrontal neurons in vitro. Eur J Neurosci. 5:1993;1494-1500.
80. Lehmenkühler C., Walden J., Speckmann E.-J. Decrease of N-methyl-D-aspartate responses by noradrenaline in the rat motor cortex in vivo. Neurosci Lett. 121:1991;5-8.
81. 1-adrenergic receptor. Glia. 2:1989;135-147.
82. Lin J.S., Roussel B., Akaoka H., Fort P., Debilly G., Jouvet M. Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res. 591:1992;319-326.
83. Loy R., Koziell D.A., Lindsey J.D., Moore R.Y. Noradrenergic innervation of the adult rat hippocampal formation. J Comp Neurol. 189:1980;699-710.
84. Lynch G., Granger R. Variations in synaptic plasticity and types of memory in corticohippocampal networks. J Cogn Neurosci. 4:1992;189-199.
85. MacDonald E., Scheinin M. Distribution and pharmacology of α2-adrenoceptors in the central nervous system. J Physiol Pharmacol. 46:1995;241-258.
86. Marighetto A., Jaffard R., Micheau J. Effects of intraseptally injected noradrenergic drugs on hippocampal sodium-dependent-high-affinity-choline-uptake in 'resting' and 'trained' mice. Brain Res. 652:1994;120-128.
87. Mathieu J.-F., Ferron A., Dewar K.M., Reader T.A. Acute and chronic effects of methylphenidate on cortical adrenoceptors in the rat. Eur J Pharmacol. 162:1989;173-178.
88. McCormick D.A. Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity. Prog Neurobiol. 39:1992;337-388.
89. McCormick D.A., Pape H.-C., Williamson A. Actions of norepinephrine in the cerebral cortex and thalamus. implications for function of the central noradrenergic system Prog Brain Res. 88:1991;293-305.
90. McCune S.K., Voigt M.M., Hill J.M. Expression of multiple alpha adrenergic receptor subtype messenger RNAs in the adult rat brain. Neuroscience. 57:1993;143-151.
91. McDonald M.P., Overmier J.B. Present imperfect. a critical review of animal models of the mnemonic impairments in Alzheimer's disease Neurosci Biobehav Rev. 22:1998;99-120.
92. McGaugh J.L. Involvement of hormonal and neuromodulatory systems in the regulation of memory storage. Annu Rev Neurosci. 12:1989;255-287.
93. McGaugh J.L., Cahill L. Interactions of neuromodulatory systems in modulating memory storage. Behav Brain Res. 83:1997;31-38.
94. Micheletti G., Warter J.-M., Marescaux C., Depaulis A., Tranchant C., Rumbach L., Vergnes M. Effects of drugs affecting noradrenergic neurotransmission in rats with spontaneous petit mal-like seizures. Eur J Pharmacol. 135:1987;397-402.
95. 1-Adrenergic receptor subtypes, inositol phosphates and sources of cell calcium. Pharmacol Rev. 40:1988;87-119.
96. 1 receptor-linked second messenger pathway Brain Res. 546:1991;83-95.
97. Mueller A.L., Hoffer B.J., Dunwiddie T.V. Noradrenergic responses in rat hippocampus. evidence for mediation by α and β receptors in the in vitro slice Brain Res. 214:1981;113-126.
98. Murphy T.J., Bylund D.B. Oxymetazoline inhibits adenylate cyclase by activation of serotonin-1 receptors in the OK cell, an established renal epithelial cell line. Mol Pharmacol. 34:1988;1-7.
99. Mynlieff M., Dunwiddie T.V. Noradrenergic depression of synaptic responses in hippocampus of rat. evidence for mediation by alpha1-receptors Neuropharmacology. 27:1988;391-398.
100. Nebigil C., Malik K.U. Comparison of signal transduction mechanism of alpha2C and alpha1A adrenergic receptor-stimulated prostaglandin synthesis. J Pharmacol Exp Ther. 263:1992;987-996.
101. Newberry N.R., Gilbert M.J. 5-Hydroxytryptamine evokes three distinct responses on the rat superior cervical ganglion in vitro. Eur J Pharmacol. 162:1989;197-205.
102. Nicholas A.P., Hökfelt T., Pieribone V.A. The distribution and significance of CNS adrenoceptors examined with in situ hybridization. Trends Pharmacol Sci. 17:1996;245-255.
103. Nicoll R.A., Malenka R.C. Contrasting properties of two forms of long-term potentiation in the hippocampus. Nature. 377:1995;115-118.
104. Niittykoski M., Ruotsalainen S., Haapalinna A., Larson J., Sirviö J. Activation of muscarinic M3-like receptors and β-adrenoceptors, but not M2-like muscarinic receptors or α-adrenoceptors, directly modulate cortico-striatal neurotransmission in vitro. Neuroscience. 90:1999;95-105.
105. Olton D.S., Papas B.C. Spatial memory and hippocampal function. Neuropsychologia. 17:1979;669-682.
106. 1-Adrenoceptors in rat dorsal raphe neurons. regulation of two potassium conductances J Physiol. 478:1994;437-447.
107. Pang K., Rose G.M. Differential effects of norepinephrine on hippocampal complex-spike and theta-neurons. Brain Res. 425:1987;146-158.
108. Patil P.N., LaPidus J.B., Tye A. Steric aspects of adrenergic drugs. J Pharm Sci. 59:1970;1205-1234.
109. Pavlides C., Kimura A., Magarinos A.M., McEwen B.S. Hippocampal homosynaptic long-term depression/depotentiation induced by adrenal steroids. Neuroscience. 68:1995;379-385. a.
110. Pavlides C., Watanabe Y., Magarinos A.M., McEwen B.S. Opposing roles of type I and type II adrenal steroid receptors in hippocampal long-term potentiation. Neuroscience. 68:1995;387-394. b.
111. Peglion J.L., Canton H., Bervoets K., Audinot V., Brocco M., Gobert A., Le-Marouille-Girardon S., Millan M.J. Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines. J Med Chem. 38:1995;4044-4055.
112. 1-selective agonist 2-(2-chloro-5-trifluoromethylphenylimino)-imidazoline (ST587). Arzneimittelforschung Drug Res. 35:1985;201-205. a.
113. 1-adrenoceptors in the CNS in anesthetized and conscious animals. Eur J Pharmacol. 107:1985;305-311. b.
114. Pierard C., Satabin P., Lagarde D., Barrere B., Guezennec C.Y., Menu J.P., Peres M. Effects of a vigilance-enhancing drug, modafinil, on rat brain metabolism. a 2D COSY 1H-NMR study Brain Res. 693:1995;251-256.
115. 1 adrenoceptors in rat brain revealed by in situ hybridization experiments utilizing subtype-specific probes. J Neurosci. 14:1994;4252-4268.
116. Pussinen R., Sirviö J. Minor role for alpha-1 adrenoceptors in the modulation of induction and early maintenance of long-term potentiation in the CA1 field of the hippocampus. J Neurosci Res. 51:1998;309-315.
117. Pussinen R., Sirviö J. Effects of D-cycloserine, a positive modulator of N-methyl-D-aspartate receptors, and ST 587, a putative alpha-1 adrenergic agonist, individually and in combination, on the non-delayed and delayed foraging behavior of rats assessed in the radial arm maze task. J Psychopharmacol. 13:1999;159-167.
118. Pussinen R., Nieminen S., Koivisto E., Haapalinna A., Riekkinen P. Sr., Sirviö J. Enhancement of intermediate-term memory by an alpha-1 agonist or a partial agonist at the glycine site of the NMDA receptor. Neurobiol Learn Mem. 67:1997;69-74.
119. Puumala T., Sirviö J. Stimulation or blockade of alpha-1 adrenoceptors affect behavioral activity, but not spatial working memory assessed by delayed non-matching to position task in rats. J Psychopharmacol. 11:1997;45-51.
120. Puumala T., Sirviö J. Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attentional task. Neuroscience. 83:1998;489-499.
121. Puumala T., Ruotsalainen S., Jäkälä P., Koivisto E., Riekkinen P. Jr., Sirviö J. Behavioral and pharmacological studies on the validation of a new model for attention deficit hyperactivity disorder. Neurobiol Learn Mem. 66:1996;198-211. a.
122. Puumala T., Sirviö J., Ruotsalainen S., Riekkinen P. Sr. Effects of St-587 and prazosin on water maze and passive avoidance performance of scopolamine-treated rats. Pharmacol Biochem Behav. 55:1996;107-115. b.
123. Puumala T., Björklund M., Ruotsalainen S., Riekkinen M., Jäkälä P., Haapalinna A., Björk E., Riekkinen P. Jr., Sirviö J. Lack of relationship between thalamic oscillations and attention in rats. differential modulation by an alpha-2 antagonist Brain Res Bull. 43:1997;163-171. a.
124. Puumala T., Riekkinen P. Sr., Sirviö J. Modulation of vigilance and behavioral activation by alpha-1 adrenoceptors in the rat. Pharmacol Biochem Behav. 56:1997;705-712. b.
125. Puumala T., Greijus S., Narinen K., Haapalinna A., Riekkinen P. Sr., Sirviö J. Stimulation of alpha-1 adrenergic receptors facilitates spatial learning in rats. Eur Neuropsychopharmacol. 8:1998;17-26.
126. Radek R.J., Curzon P., Decker M.W. Characterization of high voltage spindles and spatial memory in young, mature and aged rats. Brain Res Bull. 33:1994;183-188.
127. Ramberg F.A., Pessonnier J., Duteil J. Modafinil-, amphetamine- and methylphenidate-induced hyperactivities in mice involve different mechanisms. Eur J Pharmacol. 183:1990;455-456.
128. 1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep. Eur J Pharmacol. 205:1991;11-16.
129. 1-adrenoceptors and NMDA receptors on spatial and passive avoidance behavior in rats. Eur J Pharmacol. 300:1996;9-16.
130. Riekkinen M., Kemppainen S., Riekkinen P. Jr. Effects of stimulation of alpha1-adrenergic and NMDA/glycine-B receptors on learning defects in aged rats. Psychopharmacology. 131:1997;49-56.
131. Riekkinen P. Jr., Sirviö J., Valjakka A., Pitkänen A., Partanen J., Riekkinen P.J. The effects of concurrent manipulations of cholinergic and noradrenergic systems on neocortical EEG and spatial learning. Behav Neural Biol. 54:1990;204-210.
132. 1-Adrenoceptor antagonist decreases α2-adrenoceptor antagonist-induced high voltage spindle suppression in adult and aged rats. Eur J Pharmacol. 235:1993;317-320.
133. Robbins T.W. Arousal systems and attentional processes. Biol Psychiatry. 45:1997;57-71.
134. 1 adrenergic agonist and an α2-adrenergic antagonist. J Pharmacol Exp Ther. 222:1982;29-36.
135. Ruffolo R.R. Jr., Bondinell W., Hieble J.P. α- and β-adrenoceptors. from gene to the clinic. 2. Structure-activity relationships and therapeutic applications J Med Chem. 38:1995;3681-3716.
136. Rutecki P.A. Noradrenergic modulation of epileptiform activity in the hippocampus. Epilepsy Res. 20:1995;125-136.
137. Sahgal, A. (1985). Does vasopressin affect cerebral function? In P. H. Baylis & P. L. Padfield (Eds.), The Posterior Pituitary. Hormone Secretion in Health and Disease (pp. 325-359). New York: Marcel Dekker.
138. Saletu B., Frey R., Krupka M., Anderer P., Grunberger J., Barbanoj M.J. Differential effects of the new central adrenergic agonist modafinil and d-amphetamine on sleep and early morning behaviour in elderlies. Arzneimittelforschung. 39:1989;1268-1273.
139. Scanziani M., Gähwiler B.H., Thompson S.M. Presynaptic inhibition of excitatory synaptic transmission mediated by α adrenergic receptors in area CA3 of the rat hippocampus in vitro. J Neurosci. 13:1993;5393-5401.
140. Schulteis G., Martinez J.L. Jr. Peripheral modulation of learning and memory. enkephalins as a model system Psychopharmacology. 109:1992;347-364.
141. 1-adrenergic receptor; characterization of signal transduction pathways and mammalian tissue heterogeneity. Mol Pharmacol. 40:1991;619-626.
142. Segal M., Markram H., Richter-Levin G. Actions of norepinephrine in the rat hippocampus. Prog Brain Res. 88:1991;323-330.
143. Shenker A. The mechanism of drugs used to treat attention-deficit hyperactivity disorder. focus on catecholamine receptor pharmacology Adv Pediatr. 39:1992;337-382.
144. Simon P., Panissaud C., Costentin J. The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice. A comparison with dexamphetamine. Psychopharmacology. 114:1994;597-600.
145. Squire L.R. Memory and the hippocampus. a synthesis from findings with rats, monkeys, and humans Psychol Rev. 99:1992;195-231.
146. Squire L.R., Knowlton B.J. Memory, hippocampus and brain systems. Cazzaniga M.S. The Cognitive Neurosciences (. 1995;825-838 MIT Press, Cambridge, MA.
147. Stanford S.C., Nutt D.J., Cowen P.J. Comparison of the effects of chronic desmethylimipramine administration on α2 and β adrenoceptors in different regions of rat brain. Neuroscience. 8:1983;161-164.
148. Sternberg D.B., Isaacs K.R., Gold P.E., McGaugh J.L. Epinephrine facilitation of appetitive learning. attenuation with adrenergic antagonists Behav Neural Biol. 44:1985;447-453.
149. Sternberg D.B., Korol D., Novak G.D., McGaugh J.L. Epinephrine-induced memory facilitation. attenuation with adrenoceptor antagonists Eur J Pharmacol. 129:1986;189-193.
150. Summers R.J., McMartin L.R. Adrenoceptors and their second messenger systems. J Neurochem. 60:1993;10-23.
151. Suprenant A. The neurotransmitter noradrenaline and its receptors. Semin Neurosci. 1:1990;125-136.
152. Svensson T. Peripheral, autonomic regulation of locus coeruleus noradrenergic neurons in the brain. putative implications for psychiatry and psychopharmacology Psychopharmacology. 92:1987;1-7.
153. Tabrizchi R., Triggle C.R. The interrelationship between the effects of captopril and nifedipine on pressor responses elicited by selective alpha-adrenoceptor agonists in the pithed rat preparation. J Cardiovasc Pharmacol. 19:1992;562-567.
154. Tanganelli S., Fuxe K., Ferraro L., Janson A.M., Bianchi C. Inhibitory effects of the psychoactive drug modafinil on gamma-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig. Possible involvement of 5-hydroxytryptamine mechanisms. Naunyn Schmiedebergs Arch Pharmacol. 345:1992;461-465.
155. 1-Adrenoceptor mediated vasoconstriction in vivo to enantiomers of SK&F 89748-A. Eur J Pharmacol. 101:1984;45-55.
156. 1-adrenergic receptor subtype to the expression of the 'ventral tegmental area syndrome'. Neuroscience. 47:1992;69-76.
157. Wikberg J.E.S., Uhlén S. Further characterization of the guinea pig cerebral cortex idazoxan receptor. solubilization, distinction from the imidazole site, and demonstration of cirazoline as an idazoxan receptor-selective drug J Neurochem. 55:1990;192-203.
158. Winson J., Dahl D. Action of norepinephrine in the dentate gyrus. II. Iontophoretic studies. Exp Brain Res. 59:1985;497-506.
159. Wood P.L., Ryan R., Li M. Excitatory amino acid signal transduction in the hippocampus. role of noradrenergic afferents and nitric oxide in cGMP increases in vivo Life Sci. 51:1992;601-606.
160. 1a-adrenoceptor. Br J Pharmacol. 124:1998;213-221.
161. 1-adrenoceptors and their subtypes in human and rat hippocampus. Neuroscience. 40:1991;307-320.